Litcius/Paper detail

Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Giorgia Battipaglia, Myriam Labopin, Didier Blaise, José L. Díez‐Martín, Ali Bazarbachi, Antonı́n Vı́tek, Patrice Chevallier, Luca Castagna, Giovanni Grillo, Étienne Daguindau, Javier López‐Jiménez, Yener Koç, Annalisa Ruggeri, Arnon Nagler, Mohamad Mohty

2022Transplantation and Cellular Therapy30 citationsDOI

Topics & Concepts

MedicineTransplantationCyclophosphamideInternal medicineHazard ratioGastroenterologyBusulfanUnivariate analysisGraft-versus-host diseaseLeukemiaHematopoietic stem cell transplantationFludarabineConfidence intervalChemotherapyMultivariate analysisHematopoietic Stem Cell TransplantationAcute Myeloid Leukemia ResearchPolyomavirus and related diseases
Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation | Litcius